Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues: |
| Sagent US | 287.6 | 280.4 | 244.8 | 183.6 | 152.4 | | | |
| Omega | 30.7 | 8.6 | | | | | | |
| Total revenues | 318.3 | 289.0 | 244.8 | 183.6 | 152.4 | 74.1 | 29.2 | 12.0 |
| Revenue growth [+] | 10.1% | 18.1% | 33.3% | 20.5% | 105.8% | 153.4% | 143.4% | |
| Sagent US | 2.6% | 14.6% | 33.3% | 20.5% | | | | |
| Omega | 258.4% | | | | | | | |
| Cost of goods sold | 230.6 | 202.8 | 167.2 | 152.5 | 133.6 | 65.0 | 28.8 | 11.9 |
| Gross profit | 87.7 | 86.2 | 77.5 | 31.1 | 18.8 | 9.0 | 0.4 | 0.1 |
| Gross margin | 27.6% | 29.8% | 31.7% | 16.9% | 12.3% | 12.2% | 1.5% | 0.6% |
| Selling, general and administrative | 49.9 | 43.2 | 36.2 | 30.1 | 25.1 | 18.9 | 16.7 | 15.0 |
| Research and development | 29.1 | 26.8 | 20.3 | 17.1 | 12.8 | 11.2 | 12.4 | 14.9 |
| Equity in earnings | -2.6 | -4.0 | -2.4 | -1.3 | 2.5 | 1.5 | 1.5 | -1.1 |
| Other operating expenses | -2.6 | -4.0 | -10.3 | -1.3 | 2.5 | 1.5 | 1.5 | 1.1 |
| EBITDA [+] | 24.9 | 29.6 | 38.5 | -8.8 | -18.0 | -21.4 | -25.9 | -30.1 |
| EBITDA growth | -15.9% | -22.9% | -537.5% | -51.3% | -15.5% | -17.6% | -14.0% | |
| EBITDA margin | 7.8% | 10.3% | 15.7% | -4.8% | -11.8% | -28.8% | -88.7% | -250.8% |
| Depreciation | 13.7 | 9.5 | 7.1 | 6.0 | 3.6 | 1.2 | 0.3 | 0.2 |
| EBITA | 11.2 | 20.1 | 31.4 | -14.8 | -21.7 | -22.6 | -26.2 | -30.3 |
| EBITA margin | 3.5% | 7.0% | 12.8% | -8.1% | -14.2% | -30.5% | -89.6% | -252.5% |
| Amortization of intangibles | | | | | | | 4.0 | 1.8 |
| EBIT [+] | 11.2 | 20.1 | 31.4 | -14.8 | -21.7 | -22.6 | -30.1 | -32.1 |
| EBIT growth | -44.2% | -35.9% | -312.2% | -31.8% | -4.0% | -25.0% | -6.0% | |
| EBIT margin | 3.5% | 7.0% | 12.8% | -8.1% | -14.2% | -30.5% | -103.1% | -267.1% |
| Non-recurring items [+] | 55.8 | 1.1 | | 0.7 | | | | |
| Asset impairment | 45.2 | | | | | | | |
| Legal settlement | 2.4 | | | | | | | |
| Interest expense, net [+] | 0.8 | 2.2 | 0.9 | 1.3 | 3.9 | 1.1 | 0.4 | |
| Interest expense | 0.8 | 2.2 | 0.9 | 1.6 | 4.2 | 1.1 | 0.5 | |
| Interest income | | | | 0.3 | 0.3 | 0.0 | 0.1 | |
| Other income (expense), net [+] | -2.8 | -0.7 | 0.0 | 0.0 | -0.8 | -0.8 | | 1.6 |
| Gain (loss) on debt retirement | | | 5.0 | | | | | |
| Extraordinary gain | | | 2.9 | | | | | |
| Other | -2.8 | -0.7 | 0.0 | 0.2 | | | | |
| Pre-tax income | -48.1 | 16.2 | 30.5 | -16.8 | -26.4 | -24.5 | -30.5 | -30.5 |
| Income taxes | -26.2 | -20.8 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 54.5% | | 2.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -21.9 | 37.0 | 29.6 | -16.8 | -26.4 | -24.5 | -30.5 | -30.5 |
| Net margin | -6.9% | 12.8% | 12.1% | -9.2% | -17.3% | -33.1% | -104.5% | -253.7% |
| |
| Basic EPS [+] | ($0.67) | $1.16 | $1.01 | ($0.60) | ($1.31) | ($12.53) | ($17.13) | ($19.79) |
| Growth | -158.2% | 14.4% | -268.5% | -54.3% | -89.5% | -26.8% | -13.5% | |
| Diluted EPS [+] | ($0.67) | $1.13 | $0.99 | ($0.60) | ($1.31) | ($12.53) | ($17.13) | ($19.79) |
| Growth | -159.8% | 14.2% | -264.5% | -54.3% | -89.5% | -26.8% | -13.5% | |
| |
| Shares outstanding (basic) [+] | 32.4 | 31.9 | 29.2 | 28.0 | 20.1 | 2.0 | 1.8 | 1.5 |
| Growth | 1.7% | 9.1% | 4.4% | 39.2% | 928.4% | 9.6% | 15.9% | |
| Shares outstanding (diluted) [+] | 32.4 | 32.7 | 29.9 | 28.0 | 20.1 | 2.0 | 1.8 | 1.5 |
| Growth | -0.9% | 9.4% | 7.0% | 39.2% | 928.4% | 9.6% | 15.9% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|